RIO DE JANEIRO, BRAZIL - India’s Bharat Biotech said on Tuesday, February 9th that it was likely to export its COVID-19 vaccine to Brazil and the United Arab Emirates this week, a major success for the shot approved at home for emergency use, even without efficacy data from a late-stage trial now being conducted.
Bharat Biotech has already supplied millions of doses of COVAXIN, developed with the state-run Indian Council of Medical Research, to its home government’s inoculation drive. The government has also aggressively pushed exporting locally-made vaccines abroad as part of a diplomatic campaign . . .